MTD

Mettler-Toledo International Inc.

Healthcare · $31.1B market cap

Verdict

Share price

$1,486.19

close of Oct 3, 2026

Fair value

$760.18

Sticker Price

Payback Price

$304.07

buy price

Overpriced

MTD is Overpriced: at $1,486.19 it trades 96% above its fair value of $760.18. Its buy price (Payback Price) is $304.07, 80% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 1% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth10.0% a year✓
Equity per share growth-3.3% a year✗
Sales growth4.9% a year✗
Free cash flow growth10.9% a year✓
Return on invested capital37.7%✓

Follow MTD

Get notified when it reaches its buy price of $304.07. Free.

Create a free account

Superinvestors

2 of the investors we track hold MTD. In Q2 2026, 1 opened a position and 1 sold out. Who we track

Moves in Q2 2026

New position: Wallace Weitz

Sold out: Terry Smith

Insider activity

Since Aug 3, 2026: no open-market purchases, 5 sales worth $6.1M and 6 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Mettler-Toledo International Inc.

Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works